US Patent Issued to Immatics Biotechnologies on Feb. 18 for "Peptides and combination of peptides for use in immunotherapy against various cancers" (German Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,467, issued on Feb. 18, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Peptides and combination of peptides for use in immunotherapy against various cancers" was invented by Andrea Mahr (Tuebingen, Germany), Toni Weinschenk (Tuebingen, Germany), Colette Song (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany) and Harpreet Singh (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The pr...